However, our findings based on GEPIA2 and TCGA HNSCC datasets showed the opposite result in HNSCC, suggesting that modulating the expression level of TTC7B may have implications for improving the prognosis of patients with HNSCC. This evidence concerns the gene TTC7B and head and neck squamous cell carcinoma.